Intercept Pharmaceuticals Inc. Moves Forward With OCA REGENERATE Trial
May 20, 2015 at 12:11 PM EDT
On May 19, Intercept Pharmaceuticals Inc. announced plans for an international Phase 3 trial of OCA in patients with NASH.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.